Literature DB >> 16981082

[Systemic mast cell disease with gastrointestinal symptoms--a diagnostic questionnaire].

G J Molderings1, U Kolck, C Scheurlen, M Brüss, T Frieling, M Raithel, J Homann.   

Abstract

Systemic mast cell disease often becomes clinically manifest as a mast cell mediator activation syndrome with episodic or chronic nonspecific abdominal symptoms. As a result of genetic alterations, pathological mast cells have an increased proliferation rate as well as accumulation within different organs with consequential effect on gastrointestinal secretion, absorption, pain perception and motility caused by release of their mediators. These changes may not be detected in routine laboratory or imaging methods. This report describes how the diagnosis systemic mast cell disease can be established with a diagnostic questionnaire based on a synopsis of clinical findings relevant to a mast cell mediator activation syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16981082     DOI: 10.1055/s-2006-951337

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  8 in total

Review 1.  [Systemic mastocytosis--definition of an internal disease].

Authors:  Jürgen Homann; Ulrich W Kolck; Andreas Ehnes; Thomas Frieling; Martin Raithel; Gerhard J Molderings
Journal:  Med Klin (Munich)       Date:  2010-09-08

2.  Re: Mastocytosis--a disease of the hematopoietic stem cell. Problematic criteria.

Authors:  Jürgen Homann; Ulrich Kolck; Gerhard J Molderings
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

3.  Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects.

Authors:  Gerhard J Molderings; Kirsten Meis; Ulrich W Kolck; Jürgen Homann; Thomas Frieling
Journal:  Immunogenetics       Date:  2010-09-14       Impact factor: 2.846

4.  Restless legs syndrome is associated with mast cell activation syndrome.

Authors:  Leonard B Weinstock; Arthur S Walters; Jill B Brook; Zahid Kaleem; Lawrence B Afrin; Gerhard J Molderings
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

Review 5.  The differential diagnosis of food intolerance.

Authors:  Yurdagül Zopf; Hanns-Wolf Baenkler; Andrea Silbermann; Eckhart G Hahn; Martin Raithel
Journal:  Dtsch Arztebl Int       Date:  2009-05-22       Impact factor: 5.594

Review 6.  Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.

Authors:  Gerhard J Molderings; Stefan Brettner; Jürgen Homann; Lawrence B Afrin
Journal:  J Hematol Oncol       Date:  2011-03-22       Impact factor: 17.388

7.  Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.

Authors:  Dirk Schäfer; Peter Dreßen; Stefan Brettner; Norbert-Folke Rath; Gerhard J Molderings; Katrin Jensen; Christina Ziemann
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

8.  Familial occurrence of systemic mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Manuela Bogdanow; Rolf Fimmers; Markus M Nöthen
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.